← SynDRA
A-317491
SynDRA canonical compound SYN0020353 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | P2RX3 |
| Mechanism of action | purinergic receptor antagonist |
All known targets
Mechanisms of action (all sources)
- purinergic receptor antagonist
- P2RX3 ANTAGONIST
Cross-references
Synonyms
- [3H]A317491
- A 317491
- UNII-H327N08IPV
- H327N08IPV
- 5-{[(3-phenoxyphenyl)methyl][(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl}benzene-1,2,4-tricarboxylic acid
- A317491
- VQGBOYBIENNKMI-LJAQVGFWSA-N
- antagonist A-317491
- [3H]A 317491
- SCHEMBL1160095
- GTPL5407
- GTPL4115
- CHEMBL596234
- CTK4J0070
- BDBM86478
- DTXSID40197185
- MolPort-028-749-920
- ZINC3990058
- s8519
- 475205-49-3 (free acid)
- AKOS030526820
- CS-1250
- NCGC00165956-01
- 1,2,4-Benzenetricarboxylic acid,
- RefChem:914833
- DTXCID50119676
- A-317491 DISODIUM SALT
- [3H]A-317491
- orb1296280
- SCHEMBL29381489
- C33H27NO8
- HMS3886B12
- MFCD28044314
- A-317491 (sodium salt hydrate)?
- CCG-270075
- AC-33618
- AS-57693
- DA-50063
- HY-15568
Look up A-317491 in the interactive SynDRA portal →